access to care · England · Charity report of NHS access announcement
Fampridine access: NHS England recommendation reported
MS Trust · published 2026-07-20 · approved by our editors 9/7/2026
MS Trust reports that NHS England has recommended fampridine for people with MS who have walking difficulties. The announcement concerns access in England. Fampridine targets walking symptoms, and eligibility and suitability still require assessment by the treating team.
What this means
This concerns access in England, not a new worldwide medicine approval. Exact commissioning eligibility must be checked against the NHS document before it is added to medication profiles.
Read the original
This is our short summary. The full article belongs to MS Trust (charity_or_research_institution).
Read the original articleNHS England recommends fampridine